These Clinical Results Are Good News for AstraZeneca

These Clinical Results Are Good News for AstraZeneca

Source: 
Motley Fool
snippet: 
  • AstraZeneca indicated that Imfinzi and chemotherapy were statistically superior to chemotherapy alone.
  • A potential biliary tract cancer indication would open up a sizable market.
  • AstraZeneca is trading at a price-to-earnings growth ratio of less than one.